相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Safety and Efficacy Results of the Advanced Renal Cell Carcinoma Sorafenib Expanded Access Program in North America
Walter M. Stadler et al.
CANCER (2010)
Is advanced renal cell carcinoma becoming a chronic disease?
James Larkin et al.
LANCET (2010)
Sequential Therapy With Sorafenib and Sunitinib in Renal Cell Carcinoma
Arkadiusz Z. Dudek et al.
CANCER (2009)
Final analysis of a large open-label, noncomparative, phase 3 study of sorafenib in European patients with advanced RCC (EU-ARCCS)
J. Beck et al.
EJC SUPPLEMENTS (2009)
Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial
Bernard Escudier et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
Robert J. Motzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Sequential Sorafenib and Sunitinib for Renal Cell Carcinoma
M. P. Sablin et al.
JOURNAL OF UROLOGY (2009)
Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial
Martin E. Gore et al.
LANCET ONCOLOGY (2009)
Sequential Use of the Tyrosine Kinase Inhibitors Sorafenib and Sunitinib in Metastatic Renal Cell Carcinoma: A Retrospective Outcome Analysis
Christian Eichelberg et al.
EUROPEAN UROLOGY (2008)
Antitumor effects of sunitinib or sorafenib in patients with metastatic renal cell carcinoma who received prior antiangiogenic therapy
Ila Tamaskar et al.
JOURNAL OF UROLOGY (2008)